Shinelife Meditec: Advancing India’s Fertility MedTech Landscape Through Innovation and Accessibility

• ByStartupStory     |    September 18, 2026

For couples navigating infertility, IVF is more than a medical procedure, it is a deeply personal journey shaped by hope, time and the possibility of building a family. Behind that journey is a sophisticated ecosystem of laboratory technology, equipment and specialised expertise, much of which has traditionally relied on international suppliers. Shinelife Meditec LLP, an Indian IVF MedTech company founded in 2016, is working to change that equation by developing indigenous fertility-technology solutions in India while building capabilities for emerging and international markets. 

More than a portfolio of individual devices, Shinelife is building an integrated IVF laboratory platform that addresses different stages of the fertility-care ecosystem. Its approach spans four key areas: building laboratory infrastructure through IVF and andrology equipment and 

NEO incubators; protecting laboratory quality through monitoring, quality-control, cryopreservation and fertility-preservation solutions; operating through lab setup, installation, calibration, maintenance and application support; and scaling capabilities through professional training and simulation. The company is also looking at expanding into consumables, disposables and digital capabilities, reflecting its ambition to build a more comprehensive fertility MedTech ecosystem rather than remain limited to equipment supply. 

Founded by Nitul Parikh, a Biomedical Engineer and IIM Ahmedabad alumnus with more than 22 years of experience in the IVF and reproductive healthcare sector, Shinelife was built around a clear objective: to make advanced fertility technology more accessible, affordable and relevant to the needs of IVF laboratories. Over the years, the company has developed a diverse portfolio covering IVF and andrology laboratory equipment, benchtop incubators, IUI/IVF monitoring systems, cryopreservation devices, fertility-preservation solutions and laboratory quality-control systems. It also supports fertility centres through laboratory setup, maintenance, training and technical services, allowing it to operate across multiple stages of the fertility-care ecosystem. 

Building Indigenous Technology in a Specialised Market 

The IVF MedTech sector is a highly specialised industry where precision, reliability and laboratory conditions play a critical role. Historically, a significant share of advanced equipment used by fertility laboratories has come from international companies. Shinelife’s journey has therefore been shaped by an opportunity to develop technology within India while addressing the practical and economic requirements of Indian and other emerging markets. 

A significant milestone in this journey is the company’s NEO Series of benchtop incubators. Shinelife has developed the NEO Series as an indigenously researched, designed and manufactured solution for IVF laboratories, representing its focus on strengthening India’s capabilities in specialised fertility technology.

The development of the NEO Series reflects a larger philosophy within the company: technology for fertility laboratories should not only meet high technical standards but should also be accessible and relevant to the markets in which it is deployed. By investing in indigenous development, Shinelife aims to create solutions that can respond to local requirements while reducing some of the limitations associated with dependence on imported technologies. 

For the company, the importance of indigenous innovation extends beyond simply manufacturing a product in India. It represents an effort to create a stronger domestic technology ecosystem and demonstrate that specialised MedTech solutions can be researched, developed and manufactured from India for both Indian and international requirements. 

An End-to-End Presence Across the Fertility Ecosystem 

Shinelife’s positioning has also evolved beyond that of a conventional medical-equipment supplier. Its portfolio and services allow it to work across different stages of IVF laboratory requirements, from equipment and laboratory quality-control systems to installation, maintenance, technical support and professional training. 

The company has established a presence across India and emerging markets and currently serves 200+ clients. Its international engagement includes participation at major ESHRE exhibitions in Milan, Copenhagen, Amsterdam, Paris and London, reflecting its efforts to build visibility and relationships within the global reproductive-healthcare community. 

Its network also extends across the wider fertility chain, with major players in the IVF and fertility ecosystem forming part of its client base. This presence gives Shinelife an understanding of the requirements that laboratories and fertility centres face at different stages of their operations, while also strengthening its ability to develop solutions around practical clinical and laboratory needs. 

The company’s international orientation is becoming an increasingly important part of its growth story. As fertility care expands across emerging markets, there is an opportunity for Indian-developed technologies that combine quality, technical support and affordability to address markets beyond India. Shinelife’s participation in international platforms and its engagement with markets across regions such as the Middle East, Africa and Southeast Asia reflect this broader ambition. 

Technology With a Wider Reproductive-Health Application 

While human IVF remains at the centre of Shinelife’s business, the company’s work also touches upon veterinary and bovine IVF applications. The use of assisted reproductive technologies in livestock can support improved breeding outcomes and animal genetics, with wider relevance for India’s livestock ecosystem and the potential to contribute to better-quality milk production.

For Shinelife, this represents another dimension of how reproductive technology can create applications beyond conventional human fertility care. However, the company’s primary focus remains its work within the IVF and fertility MedTech ecosystem. 

Putting Accessibility at the Centre of Innovation 

For Shinelife, however, indigenous fertility technology is ultimately about more than equipment, manufacturing or market expansion. 

Behind every IVF laboratory is a couple hoping to build a family. 

This human reality forms an important part of the company’s larger purpose. Fertility treatment can be a complex and expensive journey, and access to advanced technology plays an important role in the infrastructure supporting that care. By developing fertility technology in India, Shinelife aims to contribute to a healthcare ecosystem where quality solutions can become more accessible and affordable. 

The company’s mission reflects this approach: to equip IVF centres with world-class technologies while combining innovation with accessible solutions that can adapt to the unique requirements of individual clinics. Its broader vision is to help bridge gaps in global healthcare by empowering fertility clinics across emerging markets with reliable technology and the ability to work towards consistent outcomes. 

This gives the company’s Made-in-India journey a larger human purpose. The objective is not simply to replace imported equipment with domestic alternatives, but to create technology that can potentially reduce barriers to accessing quality fertility infrastructure. 

At the heart of this ambition is a simple belief: every couple should have the opportunity to pursue fertility treatment and the possibility of building a family. 

A Founder-Led Journey Built on Experience 

Shinelife’s development has been closely connected to the experience of its founder, Nitul Parikh. Before establishing the company in 2016, Parikh held leadership roles across India, Africa and Asia, giving him exposure to different healthcare markets and the requirements of the IVF and reproductive-health sector. 

His contribution to the sector has also extended beyond business and product development. Through global training and simulation programmes, Parikh has helped upskill more than 3,000 IVF professionals, while continuing to contribute to professional forums including ISAR and ESHRE. 

That combination of industry experience, technical understanding and professional education has helped shape Shinelife’s approach to MedTech, one that brings together technology, clinical relevance and knowledge-sharing. 

From a Bootstrapped Business to Its Next Phase of Growth

Shinelife’s journey has been built organically as a bootstrapped business, developing its products, customer relationships and market presence over time. The company has now reached a stage where its focus is increasingly shifting towards scaling the capabilities it has built. 

Its growth plans include strengthening its manufacturing capabilities, expanding its sales and service network, introducing consumables and disposables, and increasing its presence across international markets. 

This next phase is particularly significant because it moves the company’s ambition beyond individual products towards building a larger Indian global IVF MedTech platform. The objective is to combine indigenous technology, scalable manufacturing and affordability to create solutions that can serve both India and emerging markets. 

As part of this growth journey, Shinelife is also looking at long-term strategic investment and partnerships with promoters who share its vision. Having built the business organically, the company is seeking partners who can contribute to its next stage of expansion and remain aligned with the business over the long term. 

For Shinelife, strategic capital is therefore not positioned simply as a means of financing growth. The larger objective is to find the right partners who can support manufacturing expansion, market development, international growth and the company’s ambition of creating an India-led global fertility MedTech platform. 

The company’s priorities include expanding its presence in India, building opportunities across APAC, the Middle East and Africa and Latin America, strengthening regulatory readiness, developing manufacturing and OEM capabilities, and creating a more recurring portfolio through consumables and related solutions. This is where Shinelife sees a role for long-term strategic partnerships – bringing together its specialist IVF knowledge, India-based engineering and product-development capabilities, customer relationships and emerging-market orientation with a partner’s manufacturing scale, regulatory expertise and international distribution reach. The objective is to multiply the reach of a specialist platform that has been built organically over the last decade. 

An Indian MedTech Opportunity With Global Potential 

The story of Shinelife comes at a time when India’s healthcare and MedTech ecosystem is increasingly looking beyond domestic consumption towards innovation, manufacturing and global competitiveness. 

For a specialised sector such as IVF, this opportunity is particularly significant. The ability to develop technology domestically can create greater control over product development while opening opportunities to design solutions around the requirements of emerging markets. 

Shinelife’s journey – from building a presence across the fertility technology chain to developing indigenous products, serving more than 200 clients, participating in international platforms and exploring export opportunities – reflects this larger possibility.

The company’s future ambition is therefore not limited to becoming a larger IVF equipment business. It is to establish an ecosystem where Indian innovation, manufacturing, affordability and clinical relevance come together to serve the evolving needs of fertility care. 

For the company, the next chapter will be about taking the capabilities it has built and scaling them – within India and increasingly across international markets. 

Ultimately, Shinelife’s journey is about connecting two sides of the same equation: technology and human possibility. Every incubator, laboratory system or fertility solution exists within a much larger story, that of individuals and couples seeking the opportunity to build their families. 

By investing in indigenous fertility technology and working towards more accessible solutions, Shinelife aims to contribute to that journey while strengthening India’s position in the global MedTech landscape. 

Because for Shinelife, advancing fertility technology is not simply about building better equipment. It is about building the technology and infrastructure that can help make the possibility of building a family more accessible to those who need it.

Follow Startup Story